BVMF/ONCO3 (BVMF/ONCO3)

Brazil Stock Exchange: BVMF/ONCO3 · BRL

R$0.70

-0.02 (-2.8%)· Recorded snapshot

Market cap	785.8M
Revenue (ttm)	5B
Net income (ttm)	-4.2B
EPS (ttm)	-R$4.87
Shares out	1.1B
P/E (forward)	19.8x
Volume	4,233,800
Beta	1.18

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5B
Net income (ttm): -4.2B
EPS (ttm): -R$4.87
P/E (forward): 19.8x
Market cap: 785.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E19.8

P25 11.9P50 16.6P75 25.6

Trailing P/En/a

P25 15.1P50 22.9P75 38.5

ROE-273.5

P25 2.7P50 10.8P75 20.1

ROIC-49.7

P25 6.3P50 12.1P75 21.3

Benchmarks · 1M

All BVMF/ONCO3 indicators

Market & fundamental data

Available fields

192

Groups with data

Currency

BRL

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-11-05
Enterprise value	BRL 4.6B
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2010
Industry	Medical Care Facilities
Is primary listing	Yes
ISIN number	BRONCOACNOR6
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	BRL 785.8M
Next earnings date	2026-11-05
Price	BRL 0.70
Price currency	BRL
Sector	Healthcare
SIC code	8011
Stock price date	2026-10-29
Symbol	bvmf/ONCO3
Website	https://grupooncoclinicas.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-695.6%
EV/FCF	26.21x
EV/Sales	0.93x
FCF / EV yield	3.82%
FCF yield	21.98%
Forward P/E	19.78x
P/(FCF - SBC) ratio	5.28x
P/(OCF - SBC) ratio	2.84x
P/B ratio	8.23x
P/FCF ratio	4.55x
P/OCF ratio	2.61x
P/S ratio	0.16x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-40.88%
EBITDA margin	-37.56%
FCF margin	3.56%
Gross margin	27.31%
Operating margin	-40.88%
Pretax margin	-78.57%
Profit margin	-84.77%
ROA	-15.09%
ROA (5Y)	1.38%
ROCE	-286.62%
ROE	-273.51%
ROE (5Y)	-34.8%
ROIC	-49.68%
ROIC (5Y)	1.6%
SBC / revenue	0.49%
Tax / revenue	9.04%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-28.4%
Gross profit growth (Q)	-47.88%
Gross profit growth 3Y	-8.95%
Gross profit growth 5Y	12.96%
Net income growth years	0
OCF growth 3Y	58.08%
OCF growth 5Y	102.52%
Revenue growth	-18.97%
Revenue growth (Q)	-28.45%
Revenue growth (QoQ)	-9.74%
Revenue growth 3Y	-0.29%
Revenue growth 5Y	16.22%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -131.9M
Depreciation and amortization	BRL 165.9M
EBIT	BRL -2B
EBITDA	BRL -1.9B
EPS	BRL -4.87
FCF per share	BRL 0.16
Financing cash flow	BRL -555.3M
Free cash flow	BRL 177.7M
Free cash flow minus SBC	BRL 153.2M
Gross profit	BRL 1.4B
Income taxes	BRL 451M
Investing cash flow	BRL 46.9M
Net borrowing	BRL -324.4M
Net cash flow	BRL -198.9M
Net income	BRL -4.2B
Operating cash flow minus SBC	BRL 285.1M
Operating income	BRL -2B
Revenue	BRL 5B
Stock-based compensation	BRL 24.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.75
Book value per share	BRL 0.01
Debt / equity	39.49
Debt / FCF	21.84
Goodwill	BRL 1.4B
Interest coverage	-3.28
Long-term assets	BRL 4B
Long-term liabilities	BRL 613.6M
Net cash (debt)	BRL -3.8B
Net cash / market cap	-465.94%
Net debt / equity	38.34
Net debt / FCF	21.2
Piotroski F-Score	3
Property, plant and equipment	BRL 985.7M
Shareholders' equity	BRL 98.2M
Tangible book value	BRL -2.6B
Tangible book value per share	BRL -2.30
Total assets	BRL 6.6B
Total cash	BRL 113.5M
Total debt	BRL 3.9B
Total liabilities	BRL 6.5B
WACC	12.34%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.59
Current assets	BRL 2.6B
Current liabilities	BRL 5.9B
Current ratio	0.44
Inventory turnover	16.96
Net working capital	BRL 107.6M
Quick ratio	0.31
Working capital	BRL -3.3B
Working capital turnover	-4.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-32.66%
Shareholder yield	-32.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 1.16
1D price change	-2.78%
1M price change	-31.37%
1M total return	-31.37%
1W price change	-33.33%
1W total return	-33.33%
1Y price change	-66.98%
1Y return CAGR	-67.01%
1Y total return	-66.98%
20-day SMA	BRL 0.98
200-day SMA	BRL 1.46
3M price change	14.75%
3M total return	14.75%
3Y price change	-92.72%
3Y return CAGR	-57.69%
3Y total return	-92.43%
50-day SMA	BRL 1.13
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 3.07
52-week high date	2026-01-07
52-week low	BRL 0.53
52-week low date	2026-08-10
5Y price change	-93.14%
5Y return CAGR	-41.03%
5Y total return	-92.87%
6M price change	-54.84%
6M total return	-54.84%
All-time high	BRL 19.62
All-time high date	2021-08-10
All-time low	BRL 0.53
All-time low date	2026-08-10
Average true range (ATR)	BRL 0.12
Average volume	7.3M
Beta (1Y)	0.95
Beta (2Y)	1.68
Beta (5Y)	1.18
Change from 52-week high	-77.2%
Change from 52-week low	32.08%
Change from all-time high	-96.43%
Change from all-time low	32.08%
Change from open	4.48%
Day's gap	-6.94%
Dollar volume	BRL 3M
High price	BRL 0.77
Low price	BRL 0.67
Monthly RSI	35.86
Open price	BRL 0.67
Position in 52-week range	30%
Previous close	BRL 0.72
Price vs 150-day SMA	-39.45%
Price vs 20-day SMA	-28.21%
Price vs 200-day SMA	-51.89%
Price vs 50-day SMA	-37.89%
Relative volume	0.58
RSI	31.28
Sharpe ratio	-0.02
Sharpe ratio (3Y)	-0.25
Sharpe ratio (5Y)	-0.2
Sortino ratio	0.02
Sortino ratio (3Y)	-0.33
Sortino ratio (5Y)	-0.24
Volume	4.2M
Weekly RSI	38.62
YTD price change	-74.17%
YTD total return	-74.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	569M
Shares change (QoQ)	0%
Shares change (YoY)	32.66%
Shares held by insiders	5.06%
Shares held by institutions	23.88%
Shares outstanding	1.1B

Deeper analysis on BVMF/ONCO3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/ONCO3 report

Is a complete BVMF/ONCO3 research report available?

No complete published report is available for bvmf/ONCO3 (BVMF/ONCO3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/ONCO3 (BVMF/ONCO3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/ONCO3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/ONCO3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/ONCO3

Frequently asked questions